Company Filing History:
Years Active: 2023
Title: Yang Wang - Innovator in Immunology
Introduction
Yang Wang is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of immunology through his innovative research and development. His work focuses on enhancing the efficacy of interleukin-2, a crucial protein in immune response.
Latest Patents
Yang Wang holds a patent for an "Activatable IL2 composition and methods of use." This invention includes proteins, nucleic acids, and methods for creating and utilizing an activatable interleukin-2 (aIL2). The composition comprises an interleukin-2 (IL2) fusion protein that includes a wild-type or mutein IL2, a first cleavable linker, an interleukin-2 receptor binding region (IL2RB), and a half-life extender, such as an antibody Fc region. The innovative aspect of this patent lies in the cleavage of the cleavable linker, which releases the IL2 from the interleukin-2 receptor beta binding region.
Career Highlights
Yang Wang is associated with Immune Targeting, Inc., where he continues to advance his research in immunotherapy. His work has the potential to significantly impact treatments for various diseases by improving immune responses.
Collaborations
Yang Wang collaborates with fellow researcher Tao Yue, contributing to the development of innovative solutions in the field of immunology.
Conclusion
Yang Wang is a notable inventor whose work in immunology, particularly through his patent on activatable interleukin-2, showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in immune response enhancement.